Dr. Wanqing Liu's lab at Wayne State University focuses on understanding how heavy metals interact with our genes and how these interactions may contribute to nonalcoholic fatty liver disease (NAFLD). They investigate how metal exposure affects liver cells and the overall health of the liver, aiming to provide insights that could lead to new diagnostics and treatments for liver diseases. Their work combines advanced techniques in genomics and bioinformatics to analyze human liver tissues and patient data.

Dr. Michael Rybak's lab focuses on innovative strategies to combat difficult bacterial infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). The research emphasizes the synergy between bacteriophages and antibiotics, aiming to enhance treatment efficacy and prevent resistance. By combining these therapies, the lab seeks to improve patient outcomes and translate findings into clinical applications.